Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

Drugs Market Growth is Driven by Rising Consumer Awareness, Growth of Lifestyle Diseases, and Expanding Distribution Channels Drive Market Growth; U.S. and Asia-Pacific Regions See Notable ...

Dozens of over-the-counter acne products had very high levels of the known carcinogen benzene, even when they were taken ...

Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...

Supply chain leaders (93%) are at least somewhat confident in their supply chain’s resilience against future disruptions, ...

AI is not a new technology in the supply chain realm; it has been used in some cases for decades. More recently, many other ...

Sanofi India Limited (Previously known as Aventis Pharma Limited) was incorporated in May 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11 2012. The ...

However, it is essential that supply chain partners not only recognise these advancements, but also embrace the challenge to exceed expectations by unlocking and integrating data from diverse ...

Wall Street’s benchmark index dropped almost 1 per cent to finish at 5,695, the lowest level since September 19. The technology-heavy Nasdaq Composite dropped 1.2 per cent.

Nagano, Japan-headquartered Maruichi Sansho is forming an aquaculture business division after acquiring Dainichi for JPY ...

The global dysmenorrhea treatment market, valued at approximately USD 5,937.8 million in 2022, is projected to reach USD 6,324.5 million in 2023 and USD 13,106.5 million by 2032, exhibiting a CAGR of ...

The Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital Association (AHA) has ...